576 related articles for article (PubMed ID: 24100629)
1. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
[TBL] [Abstract][Full Text] [Related]
2. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
[TBL] [Abstract][Full Text] [Related]
3. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.
Liu J; Wang F
Front Immunol; 2017; 8():1005. PubMed ID: 28871262
[TBL] [Abstract][Full Text] [Related]
4. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.
Pehar M; Harlan BA; Killoy KM; Vargas MR
Curr Pharm Des; 2017; 23(33):5010-5021. PubMed ID: 28641533
[TBL] [Abstract][Full Text] [Related]
5. The multi-dimensional roles of astrocytes in ALS.
Yamanaka K; Komine O
Neurosci Res; 2018 Jan; 126():31-38. PubMed ID: 29054467
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
Thonhoff JR; Ojeda L; Wu P
Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
[TBL] [Abstract][Full Text] [Related]
7. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.
Malaspina A; Puentes F; Amor S
Int Immunol; 2015 Mar; 27(3):117-29. PubMed ID: 25344935
[TBL] [Abstract][Full Text] [Related]
8. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
9. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
Evans MC; Couch Y; Sibson N; Turner MR
Mol Cell Neurosci; 2013 Mar; 53():34-41. PubMed ID: 23110760
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia.
Rossi S; Cozzolino M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831228
[TBL] [Abstract][Full Text] [Related]
12. A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.
Vallarola A; Tortarolo M; De Gioia R; Iamele L; de Jonge H; de Nola G; Bovio E; Pasetto L; Bonetto V; Freschi M; Bendotti C; Gherardi E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198383
[TBL] [Abstract][Full Text] [Related]
13. Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.
Vahsen BF; Gray E; Thompson AG; Ansorge O; Anthony DC; Cowley SA; Talbot K; Turner MR
Nat Rev Neurol; 2021 Jun; 17(6):333-348. PubMed ID: 33927394
[TBL] [Abstract][Full Text] [Related]
14. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
15. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
16. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
18. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model.
Matsumoto T; Imagama S; Hirano K; Ohgomori T; Natori T; Kobayashi K; Muramoto A; Ishiguro N; Kadomatsu K
Neurosci Lett; 2012 Jun; 520(1):115-20. PubMed ID: 22634473
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological role of prostaglandin E2-induced up-regulation of the EP2 receptor in motor neuron-like NSC-34 cells and lumbar motor neurons in ALS model mice.
Kosuge Y; Miyagishi H; Yoneoka Y; Yoneda K; Nango H; Ishige K; Ito Y
Neurochem Int; 2018 Oct; 119():132-139. PubMed ID: 28687401
[TBL] [Abstract][Full Text] [Related]
20. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.
Motataianu A; Barcutean L; Balasa R
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):159-166. PubMed ID: 31903792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
